NCT00737867View on ClinicalTrials.gov

Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

444

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Advanced Non-Small Cell Lung Cancer
Interventions
DRUG

Vinorelbine

Day 1: Vinorelbine capsules 60 mg/m2 Day 8: Vinorelbine capsules 60 mg/m2

DRUG

Gemcitabine

Day 1: Gemcitabine infusion 1000 mg/m2 Day 8: Gemcitabine infusion 1000 mg/m2

DRUG

Vinorelbine

Day 1: Vinorelbine capsules 60 mg/m2 Day 8: Vinorelbine capsules 60 mg/m2

DRUG

Carboplatin

Day 1: Carboplatin infusion AUC = 5 (Calvert's formula)

Trial Locations (4)

5000

Øystein Fløtten, Bergen

7000

Sverre Fluge, Haugesund

Tore Amundsen, Trondheim

Unknown

Heidi Rolke, Kristiansand

All Listed Sponsors
lead

The Norwegian Lung Cancer Study Group

NETWORK

NCT00737867 - Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter